Investors sell off AMD shares despite the company's pivot to life sciences AI, following a rating downgrade by HSBC that followed a six-month decline in the stock price.

Eligibility for treatment with the latest cancer drugs is often determined by genetic mutations in tumors, criteria that ...

An AI system developed to predict a patient's response to immunotherapy could help "democratize" access to the pricey drugs ...

Greater transparency, monitoring, and regulatory oversight are needed around these transactions, a researcher says.

A new study found that fewer African and Asian patients had clinically actionable alterations for lung, breast, and colorectal cancer.

A University of Oklahoma professor and his team have discovered a new way to put atoms into drug molecules that could ...

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

During the 66th American Society of Hematology Annual Meeting and Exposition, investigators revealed early-phase 1 data evaluating various BTK degraders that leverage different strategies to overcome ...

Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.

Neuroscience Innovation Forum14th Annual LifeSci Advisors Corporate Access EventInvest Securities BioMed Forum 2025MidCap Events ...

U.S. Surgeon General Vivek Murthy issued a new report on alcohol and cancer, which emphasizes the risk of cancer in ...